Vectura Group (VEC)

Sector: Pharma and Biotech     Index: FTSE 250
0.09%
0.10p
114.80p
08:24 29/06/17
114.80p
08:24 29/06/17
DAILY VARIATION
0.09%
0.10p
VOLUME
14,942
REAL TIME BATS
113.80p
08:27 29/06/17
-0.44%
-0.50p
DATA
52 Week High
163.00p
52 Week Low
112.20p
Shares Issued
679.34m
Market Cap
£779.89m
RiskGrade
160
Beta
0.58
MENU

Vectura Group Overview

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -35.2% -27.1%
ROCE 0.0%
Latest F'cast
P/E 15.4 29.6
PEG 0.5 -0.6
Pr/Revenue 4.6 4.6
Pr/Book 1.2
Latest F'cast
Revenue 133.2% 81.7%
PBT 0.0% n/a
EPS 30.4% -63.7%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2013-03-31 30.50 -10.40 -1.80p -50.4 0.0 n/a n/a 0.0%
2014-03-31 36.50 -4.80 1.50p 102.2 0.0 n/a n/a 0.0%
2015-03-31 58.00 -6.20 4.00p 36.4 0.2 167% n/a 0.0%
2016-03-31 72.00 -1.90 5.70p 28.5 0.7 42% n/a 0.0%
2016-12-31 126.50 -40.10 7.43p 18.4 0.6 30% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 169.56 -45.93 3.85p 29.6 -0.6 -48% 0.00p 0.0%
2018-12-31 206.40 -28.24 5.94p 17.6 0.3 54% 0.00p 0.0%

Regulatory News

slide to see more
New development and licence agreement 28-Jun-17 17:16
Holding(s) in Company 16-Jun-17 15:00
Holdings in Company 12-Jun-17 07:04

Newspaper Links

No results found